ATP-dependent potassium channels and type 2 diabetes mellitus

Clinical Biochemistry

Volumn 48, Issue 7-8, 2015, Pages 476-482

  Bonfanti, Dianne Heloisa ^a   Alcazar, Larissa Pontes ^a   Arakaki, Priscila Akemi ^a   Martins, Laysa Toschi ^a   Agustini, Bruna Carla ^a   de Moraes Rego, Fabiane Gomes ^a   Frigeri, Henrique Ravanhol ^a  

^a PONTIFICAL CATHOLIC UNIVERSITY OF PARANÁ   (Brazil)

Author keywords

ABCC8; E23K; I337V; KCNJ11; Obesity; Polymorphisms; Potassium channels; S1369A; T2DM

Indexed keywords

ADENOSINE TRIPHOSPHATE; INWARDLY RECTIFYING POTASSIUM CHANNEL; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR6.2; POTASSIUM CHANNEL; SULFONYLUREA RECEPTOR;

ANIMAL; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; HUMAN; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS;

ADENOSINE TRIPHOSPHATE; ANIMALS; DIABETES MELLITUS, TYPE 2; GENETIC PREDISPOSITION TO DISEASE; HUMANS; POLYMORPHISM, GENETIC; POTASSIUM CHANNELS; POTASSIUM CHANNELS, INWARDLY RECTIFYING; SULFONYLUREA RECEPTORS;

EID: 84939935479     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2014.12.026     Document Type: Review

References (110)

1. Ahlqvist E., Ahluwalia T.S., Groop L. Genetics of type 2 diabetes. Clin Chem 2011, 57:241-254.
2. Barroso I. Genetics of type 2 diabetes. Diabet Med 2005, 22:517-535.
3. Kota S.K., Meher L.K., Jammula S., Modi K.D. Genetics of type 2 diabetes mellitus and other specific types of diabetes; its role in treatment modalities. Diabetes Metab Syndr 2012, 6:54-58.
4. Sladek R., Rocheleau G., Rung J., et al. A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature 2007, 445:881-885.
5. Brunetti A., Chiefari E., Foti D. Recent advances in the molecular genetics of type 2 diabetes mellitus. World J Diabetes 2014, 5:128-140.
6. Groop L., Pociot F. Genetics of diabetes-are we missing the genes or the disease?. Mol Cell Endocrinol 2014, 382:726-739.
7. ADA Diagnosis and classification of diabetes mellitus. Diabetes Care 2014, 37(Suppl. 1):S81-S90.
8. Barroso I., Luan J., Middelberg R.P., et al. Candidate gene association study in type 2 diabetes indicates a role for genes involved in beta-cell function as well as insulin action. PLoS Biol 2003, 1:E20.
9. Chistiakov D.A., Potapov V.A., Khodirev D.S., Shamkhalova M.S., Shestakova M.V., Nosikov V.V. The KCNJ11 E23K and ABCC8 exon 31 variants contribute to susceptibility to type 2 diabetes, glucose intolerance and altered insulin secretion in a Russian population. Diabetes Metab Syndr Clin Res Rev 2008, 2:185-191.
10. Cho Y.M., Kim T.H., Lim S., et al. Type 2 diabetes-associated genetic variants discovered in the recent genome-wide association studies are related to gestational diabetes mellitus in the Korean population. Diabetologia 2009, 52:253-261.
11. Ciccacci C., Di Fusco D., Cacciotti L., et al. TCF7L2 gene polymorphisms and type 2 diabetes: association with diabetic retinopathy and cardiovascular autonomic neuropathy. Acta Diabetol 2013, 50:789-799.
12. Sakamoto Y., Inoue H., Keshavarz P., et al. SNPs in the KCNJ11-ABCC8 gene locus are associated with type 2 diabetes and blood pressure levels in the Japanese population. J Hum Genet 2007, 52:781-793.
13. van Dam R.M., Hoebee B., Seidell J.C., Schaap M.M., de Bruin T.W., Feskens E.J. Common variants in the ATP-sensitive K+ channel genes KCNJ11 (Kir6.2) and ABCC8 (SUR1) in relation to glucose intolerance: population-based studies and meta-analyses. Diabet Med 2005, 22:590-598.
14. Zhou D., Zhang D., Liu Y., et al. The E23K variation in the KCNJ11 gene is associated with type 2 diabetes in Chinese and East Asian population. J Hum Genet 2009, 54:433-435.
15. Qin L.J., Lv Y., Huang Q.Y. Meta-analysis of association of common variants in the KCNJ11-ABCC8 region with type 2 diabetes. Genet Mol Res 2013, 12:2990-3002.
16. Aguilar-Bryan L., Bryan J. Molecular biology of adenosine triphosphate-sensitive potassium channels. Endocr Rev 1999, 20:101-135.
17. Laukkanen O., Pihlajamaki J., Lindstrom J., et al. Polymorphisms of the SUR1 (ABCC8) and Kir6.2 (KCNJ11) genes predict the conversion from impaired glucose tolerance to type 2 diabetes. J Clin Endocrinol Metab 2004, 89:6286-6290.
18. Reis A.F., Ye W.Z., Dubois-Laforgue D., Bellanne-Chantelot C., Timsit J., Velho G. Association of a variant in exon 31 of the sulfonylurea receptor 1 (SUR1) gene with type 2 diabetes mellitus in French Caucasians. Hum Genet 2000, 107:138-144.
19. Rissanen J., Markkanen A., Karkkainen P., et al. Sulfonylurea receptor 1 gene variants are associated with gestational diabetes and type 2 diabetes but not with altered secretion of insulin. Diabetes Care 2000, 23:70-73.
20. Chen L., Magliano D.J., Zimmet P.Z. The worldwide epidemiology of type 2 diabetes mellitus-present and future perspectives. Nat Rev Endocrinol 2012, 8:228-236.
21. Wild S., Roglic G., Green A., Sicree R., King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004, 27:1047-1053.
22. WHO Obesity and overweight Available in:, [26/03/2014: 26/03/2014]. http://www.who.int/mediacentre/factsheets/fs311/en/.
23. Ye J. Mechanisms of insulin resistance in obesity. Front Med 2013, 7:14-24.
24. Wilcox G. Insulin and insulin resistance. Clin Biochem Rev Aust Assoc Clin Biochem 2005, 26:19-39.
25. Larsen M.O. Beta-cell function and mass in type 2 diabetes. Dan Med Bull 2009, 56:153-164.
26. Prentki M., Nolan C.J. Islet beta cell failure in type 2 diabetes. J Clin Invest 2006, 116:1802-1812.
27. Aguilar-Bryan L., Bryan J., Nakazaki M. Of mice and men: K(ATP) channels and insulin secretion. Recent Prog Horm Res 2001, 56:47-68.
28. Dedoussis G.V., Kaliora A.C., Panagiotakos D.B. Genes, diet and type 2 diabetes mellitus: a review. Rev Diabet Stud 2007, 4:13-24.
29. Beck-Nielsen H., Vaag A., Poulsen P., Gaster M. Metabolic and genetic influence on glucose metabolism in type 2 diabetic subjects-experiences from relatives and twin studies. Best Pract Res Clin Endocrinol Metab 2003, 17:445-467.
30. Elbein S.C. Perspective: the search for genes for type 2 diabetes in the post-genome era. Endocrinology 2002, 143:2012-2018.
31. Kopp W. High-insulinogenic nutrition-an etiologic factor for obesity and the metabolic syndrome?. Metabolism 2003, 52:840-844.
32. McCarthy M.I. Growing evidence for diabetes susceptibility genes from genome scan data. Curr Diab Rep 2003, 3:159-167.
33. Owen K.R., McCarthy M.I. Genetics of type 2 diabetes. Curr Opin Genet Dev 2007, 17:239-244.
34. Riedel M.J., Boora P., Steckley D., de Vries G., Light P.E. Kir6.2 polymorphisms sensitize beta-cell ATP-sensitive potassium channels to activation by acyl CoAs: a possible cellular mechanism for increased susceptibility to type 2 diabetes?. Diabetes 2003, 52:2630-2635.
35. Willer C.J., Bonnycastle L.L., Conneely K.N., et al. Screening of 134 single nucleotide polymorphisms (SNPs) previously associated with type 2 diabetes replicates association with 12 SNPs in nine genes. Diabetes 2007, 56:256-264.
36. Imamura M., Maeda S. Genetics of type 2 diabetes: the GWAS era and future perspectives [Review]. Endocr J 2011, 58:723-739.
37. McCarthy M.I., Zeggini E. Genome-wide association studies in type 2 diabetes. Curr Diab Rep 2009, 9:164-171.
38. Rich S.S., Norris J.M., Rotter J.I. Genes associated with risk of type 2 diabetes identified by a candidate-wide association scan: as a trickle becomes a flood. Diabetes 2008, 57:2915-2917.
39. Almind K., Doria A., Kahn C.R. Putting the genes for type II diabetes on the map. Nat Med 2001, 7:277-279.
40. Chen L.L., Han S.M., Tang F.F., Li Q. MTLRP genetic polymorphism (214C>A) was associated with Type 2 diabetes in Caucasian population: a meta-analysis. Lipids Health Dis 2014, 13:124.
41. Li Y.Y., Wang L.S., Lu X.Z., et al. CDKAL1 gene rs7756992 A/G polymorphism and type 2 diabetes mellitus: a meta-analysis of 62,567 subjects. Sci Rep 2013, 3:3131.
42. Lyssenko V., Laakso M. Genetic screening for the risk of type 2 diabetes: worthless or valuable?. Diabetes Care 2013, 36(Suppl. 2):S120-S126.
43. Spellman C.W. Pathophysiology of type 2 diabetes: targeting islet cell dysfunction. J Am Osteopath Assoc 2010, 110:S2-S7.
44. Zheng X., Ren W., Zhang S., et al. Association of type 2 diabetes susceptibility genes (TCF7L2, SLC30A8, PCSK1 and PCSK2) and proinsulin conversion in a Chinese population. Mol Biol Rep 2012, 39:17-23.
45. Gupta V., Khadgawat R., Ng H.K., et al. A validation study of type 2 diabetes-related variants of the TCF7L2, HHEX, KCNJ11, and ADIPOQ genes in one endogamous ethnic group of north India. Ann Hum Genet 2010, 74:361-368.
46. Prokopenko I., McCarthy M.I., Lindgren C.M. Type 2 diabetes: new genes, new understanding. Trends Genet 2008, 24:613-621.
47. Malecki M.T., Klupa T. Type 2 diabetes mellitus: from genes to disease. Pharmacol Rep 2005, 57:20-32. [Suppl.].
48. Gloyn A.L. The search for type 2 diabetes genes. Ageing Res Rev 2003, 2:111-127.
49. Fatehi M., Raja M., Carter C., Soliman D., Holt A., Light P.E. The ATP-sensitive K(+) channel ABCC8 S1369A type 2 diabetes risk variant increases MgATPase activity. Diabetes 2012, 61:241-249.
50. Gloyn A.L., Weedon M.N., Owen K.R., et al. Large-scale association studies of variants in genes encoding the pancreatic beta-cell KATP channel subunits Kir6.2 (KCNJ11) and SUR1 (ABCC8) confirm that the KCNJ11 E23K variant is associated with type 2 diabetes. Diabetes 2003, 52:568-572.
51. Gloyn A.L., Hashim Y., Ashcroft S.J., et al. Association studies of variants in promoter and coding regions of beta-cell ATP-sensitive K-channel genes SUR1 and Kir6.2 with Type 2 diabetes mellitus (UKPDS 53). Diabet Med 2001, 18:206-212.
52. Bennett K., James C., Hussain K. Pancreatic beta-cell KATP channels: hypoglycaemia and hyperglycaemia. Rev Endocr Metab Disord 2010, 11:157-163.
53. Jacobson D.A., Philipson L.H. Action potentials and insulin secretion: new insights into the role of Kv channels. Diabetes Obes Metab 2007, 9(Suppl. 2):89-98.
54. Aittoniemi J., Fotinou C., Craig T.J., de Wet H., Proks P., Ashcroft F.M. Review. SUR1: a unique ATP-binding cassette protein that functions as an ion channel regulator. Philos Trans R Soc Lond B Biol Sci 2009, 364:257-267.
55. Gloyn A.L., Siddiqui J., Ellard S. Mutations in the genes encoding the pancreatic beta-cell KATP channel subunits Kir6.2 (KCNJ11) and SUR1 (ABCC8) in diabetes mellitus and hyperinsulinism. Hum Mutat 2006, 27:220-231.
56. Miki T., Iwanaga T., Nagashima K., Ihara Y., Seino S. Roles of ATP-sensitive K+ channels in cell survival and differentiation in the endocrine pancreas. Diabetes 2001, 50(Suppl. 1):S48-S51.
57. Chan K.W., Zhang H., Logothetis D.E. N-terminal transmembrane domain of the SUR controls trafficking and gating of Kir6 channel subunits. EMBO J 2003, 22:3833-3843.
58. Lorenz E., Alekseev A.E., Krapivinsky G.B., Carrasco A.J., Clapham D.E., Terzic A. Evidence for direct physical association between a K+ channel (Kir6.2) and an ATP-binding cassette protein (SUR1) which affects cellular distribution and kinetic behavior of an ATP-sensitive K+ channel. Mol Cell Biol 1998, 18:1652-1659.
59. Zerangue N., Schwappach B., Jan Y.N., Jan L.Y. A new ER trafficking signal regulates the subunit stoichiometry of plasma membrane K(ATP) channels. Neuron 1999, 22:537-548.
60. Miki T., Nagashima K., Seino S. The structure and function of the ATP-sensitive K+ channel in insulin-secreting pancreatic beta-cells. J Mol Endocrinol 1999, 22:113-123.
61. Reimann F., Gribble F.M., Ashcroft F.M. Differential response of K(ATP) channels containing SUR2A or SUR2B subunits to nucleotides and pinacidil. Mol Pharmacol 2000, 58:1318-1325.
62. Zingman L.V., Alekseev A.E., Bienengraeber M., et al. Signaling in channel/enzyme multimers: ATPase transitions in SUR module gate ATP-sensitive K+ conductance. Neuron 2001, 31:233-245.
63. Flanagan S.E., Clauin S., Bellanne-Chantelot C., et al. Update of mutations in the genes encoding the pancreatic beta-cell K(ATP) channel subunits Kir6.2 (KCNJ11) and sulfonylurea receptor 1 (ABCC8) in diabetes mellitus and hyperinsulinism. Hum Mutat 2009, 30:170-180.
64. Ashcroft F.M. ATP-sensitive potassium channelopathies: focus on insulin secretion. J Clin Invest 2005, 115:2047-2058.
65. Lin C.W., Lin Y.W., Yan F.F., et al. Kir6.2 mutations associated with neonatal diabetes reduce expression of ATP-sensitive K+ channels: implications in disease mechanism and sulfonylurea therapy. Diabetes 2006, 55:1738-1746.
66. Doyle D.A., Morais Cabral J., Pfuetzner R.A., et al. The structure of the potassium channel: molecular basis of K+ conduction and selectivity. Science 1998, 280:69-77.
67. Hamming K.S., Soliman D., Matemisz L.C., et al. Coexpression of the type 2 diabetes susceptibility gene variants KCNJ11 E23K and ABCC8 S1369A alter the ATP and sulfonylurea sensitivities of the ATP-sensitive K(+) channel. Diabetes 2009, 58:2419-2424.
68. Lang V.Y., Fatehi M., Light P.E. Pharmacogenomic analysis of ATP-sensitive potassium channels coexpressing the common type 2 diabetes risk variants E23K and S1369A. Pharmacogenet Genomics 2012, 22:206-214.
69. Ashcroft F.M., Harrison D.E., Ashcroft S.J. Glucose induces closure of single potassium channels in isolated rat pancreatic beta-cells. Nature 1984, 312:446-448.
70. Stumvoll M., Fritsche A., Haring H.U. Clinical characterization of insulin secretion as the basis for genetic analyses. Diabetes 2002, 51(Suppl. 1):S122-S129.
71. Villareal D.T., Koster J.C., Robertson H., et al. Kir6.2 variant E23K increases ATP-sensitive K+ channel activity and is associated with impaired insulin release and enhanced insulin sensitivity in adults with normal glucose tolerance. Diabetes 2009, 58:1869-1878.
72. Meier J.J., Bonadonna R.C. Role of reduced beta-cell mass versus impaired beta-cell function in the pathogenesis of type 2 diabetes. Diabetes Care 2013, 36(Suppl. 2):S113-S119.
73. Rosengren A.H., Braun M., Mahdi T., et al. Reduced insulin exocytosis in human pancreatic beta-cells with gene variants linked to type 2 diabetes. Diabetes 2012, 61:1726-1733.
74. Gloyn A.L., Pearson E.R., Antcliff J.F., et al. Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes. N Engl J Med 2004, 350:1838-1849.
75. Thomas P., Ye Y., Lightner E. Mutation of the pancreatic islet inward rectifier Kir6.2 also leads to familial persistent hyperinsulinemic hypoglycemia of infancy. Hum Mol Genet 1996, 5:1809-1812.
76. Thomas P.M., Cote G.J., Wohllk N., et al. Mutations in the sulfonylurea receptor gene in familial persistent hyperinsulinemic hypoglycemia of infancy. Science 1995, 268:426-429.
77. Koster J.C., Permutt M.A., Nichols C.G. Diabetes and insulin secretion: the ATP-sensitive K+ channel (K ATP) connection. Diabetes 2005, 54:3065-3072.
78. Life-TechnologiesTM SNP genotyping analysis using TaqMan® assays Available in:, [24-06-2014: 24-06-2014]. https://www.lifetechnologies.com/br/en/home/life-science/pcr/real-time-pcr/real-time-pcr-assays/snp-genotyping-taqman-assays.html.
79. Life-TechnologiesTM TaqMan® SNP genotyping assays Available in:, [29-06-2014: 29-06-2014]. https://tools.lifetechnologies.com/content/sfs/brochures/cms_040597.pdf.
80. Aquilante C.L. Sulfonylurea pharmacogenomics in Type 2 diabetes: the influence of drug target and diabetes risk polymorphisms. Expert Rev Cardiovasc Ther 2010, 8:359-372.
81. Duan R.F., Cui W.Y., Wang H. Association of the antihypertensive response of iptakalim with KCNJ11 (Kir6.2 gene) polymorphisms in Chinese Han hypertensive patients. Acta Pharmacol Sin 2011, 32:1078-1084.
82. Florez J.C., Burtt N., de Bakker P.I., et al. Haplotype structure and genotype-phenotype correlations of the sulfonylurea receptor and the islet ATP-sensitive potassium channel gene region. Diabetes 2004, 53:1360-1368.
83. Inoue H., Ferrer J., Warren-Perry M., et al. Sequence variants in the pancreatic islet beta-cell inwardly rectifying K+ channel Kir6.2 (Bir) gene: identification and lack of role in Caucasian patients with NIDDM. Diabetes 1997, 46:502-507.
84. Hani E.H., Boutin P., Durand E., et al. Missense mutations in the pancreatic islet beta cell inwardly rectifying K+ channel gene (KIR6.2/BIR): a meta-analysis suggests a role in the polygenic basis of Type II diabetes mellitus in Caucasians. Diabetologia 1998, 41:1511-1515.
85. Gonen M.S., Arikoglu H., Erkoc Kaya D., et al. Effects of single nucleotide polymorphisms in K(ATP) channel genes on type 2 diabetes in a Turkish population. Arch Med Res 2012, 43:317-323.
86. Shemer R., Avnon Ziv C., Laiba E., et al. Relative expression of a dominant mutated ABCC8 allele determines the clinical manifestation of congenital hyperinsulinism. Diabetes 2012, 61:258-263.
87. He Y.Y., Zhang R., Shao X.Y., et al. Association of KCNJ11 and ABCC8 genetic polymorphisms with response to repaglinide in Chinese diabetic patients. Acta Pharmacol Sin 2008, 29:983-989.
88. Zhang H., Liu X., Kuang H., Yi R., Xing H. Association of sulfonylurea receptor 1 genotype with therapeutic response to gliclazide in type 2 diabetes. Diabetes Res Clin Pract 2007, 77:58-61.
89. Schwanstecher C., Schwanstecher M. Nucleotide sensitivity of pancreatic ATP-sensitive potassium channels and type 2 diabetes. Diabetes 2002, 51(Suppl. 3):S358-S362.
90. Riedel M.J., Steckley D.C., Light P.E. Current status of the E23K Kir6.2 polymorphism: implications for type-2 diabetes. Hum Genet 2005, 116:133-145.
91. Garlid K.D., Dos Santos P., Xie Z.J., Costa A.D., Paucek P. Mitochondrial potassium transport: the role of the mitochondrial ATP-sensitive K(+) channel in cardiac function and cardioprotection. Biochim Biophys Acta 2003, 1606:1-21.
92. Schwanstecher C., Meyer U., Schwanstecher M. K(IR)6.2 polymorphism predisposes to type 2 diabetes by inducing overactivity of pancreatic beta-cell ATP-sensitive K(+) channels. Diabetes 2002, 51:875-879.
93. Schwanstecher C., Neugebauer B., Schulz M., Schwanstecher M. The common single nucleotide polymorphism E23K in K(IR)6.2 sensitizes pancreatic beta-cell ATP-sensitive potassium channels toward activation through nucleoside diphosphates. Diabetes 2002, 51(Suppl. 3):S363-S367.
94. Nielsen E.M., Hansen L., Carstensen B., et al. The E23K variant of Kir6.2 associates with impaired post-OGTT serum insulin response and increased risk of type 2 diabetes. Diabetes 2003, 52:573-577.
95. Sesti G., Laratta E., Cardellini M., et al. The E23K variant of KCNJ11 encoding the pancreatic beta-cell adenosine 5'-triphosphate-sensitive potassium channel subunit Kir6.2 is associated with an increased risk of secondary failure to sulfonylurea in patients with type 2 diabetes. J Clin Endocrinol Metab 2006, 91:2334-2339.
96. Qiu L., Na R., Xu R., et al. Quantitative assessment of the effect of KCNJ11 gene polymorphism on the risk of type 2 diabetes. PLoS One 2014, 9:e93961.
97. Li Y.Y. The KCNJ11 E23K gene polymorphism and type 2 diabetes mellitus in the Chinese Han population: a meta-analysis of 6,109 subjects. Mol Biol Rep 2013, 40:141-146.
98. Hattersley A.T. Molecular genetics goes to the diabetes clinic. Clin Med 2005, 5:476-481.
99. Hattersley A.T., Ashcroft F.M. Activating mutations in Kir6.2 and neonatal diabetes: new clinical syndromes, new scientific insights, and new therapy. Diabetes 2005, 54:2503-2513.
100. Alsmadi O., Al-Rubeaan K., Wakil S.M., et al. Genetic study of Saudi diabetes (GSSD): significant association of the KCNJ11 E23K polymorphism with type 2 diabetes. Diabetes Metab Res Rev 2008, 24:137-140.
101. Doi Y., Kubo M., Ninomiya T., et al. Impact of Kir6.2 E23K polymorphism on the development of type 2 diabetes in a general Japanese population: The Hisayama Study. Diabetes 2007, 56:2829-2833.
102. Palmer N.D., Langefeld C.D., Bryer-Ash M., Rotter J.I., Taylor K.D., Bowden D.W. Association of the Kir6.2 E23K variant with reduced acute insulin response in African-Americans. J Clin Endocrinol Metab 2008, 93:4979-4983.
103. Keshavarz P., Habibipour R., Ghasemi M., Kazemnezhad E., Alizadeh M., Omami M.H. Lack of genetic susceptibility of KCNJ11 E23K polymorphism with risk of type 2 diabetes in an Iranian population. Endocr Res 2014, 39:120-125.
104. Hansen S.K., Nielsen E.M., Ek J., et al. Analysis of separate and combined effects of common variation in KCNJ11 and PPARG on risk of type 2 diabetes. J Clin Endocrinol Metab 2005, 90:3629-3637.
105. Saxena R., Voight B.F., Lyssenko V., et al. Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science 2007, 316:1331-1336.
106. Voight B.F., Scott L.J., Steinthorsdottir V., et al. Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat Genet 2010, 42:579-589.
107. Zeggini E., Weedon M.N., Lindgren C.M., et al. Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes. Science 2007, 316:1336-1341.
108. Florez J.C., Jablonski K.A., Kahn S.E., et al. Type 2 diabetes-associated missense polymorphisms KCNJ11 E23K and ABCC8 A1369S influence progression to diabetes and response to interventions in the Diabetes Prevention Program. Diabetes 2007, 56:531-536.
109. Love-Gregory L., Wasson J., Lin J., Skolnick G., Suarez B., Permutt M.A. E23K single nucleotide polymorphism in the islet ATP-sensitive potassium channel gene (Kir6.2) contributes as much to the risk of Type II diabetes in Caucasians as the PPARgamma Pro12Ala variant. Diabetologia 2003, 46:136-137.
110. t Hart L.M., van Haeften T.W., Dekker J.M., Bot M., Heine R.J., Maassen J.A. Variations in insulin secretion in carriers of the E23K variant in the KIR6.2 subunit of the ATP-sensitive K(+) channel in the beta-cell. Diabetes 2002, 51:3135-3138.